Russian Coronavirus Vaccine Trials To Be Held In Saudi Arabia

Eurasia Review

Published

Saudi Arabia is set to play a key role in the development of a Russian COVID-19 vaccine that produced promising results in the first phase of human trials.

The monthlong trial on 38 people ended this week, and a 100-person Phase II trial is under way.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said...

Full Article